Sotabase

Career

· Postdoctoral Researcher, Salk Institute for Biological Studies2023–
· Graduate Fellowship, Stanford University2020–2021
· Conference Chair, Listen to the Silence2017–2019
· Outreach Coordinator, Stanford Society of Women Engineers2016–2018
· Bachelor's degree Computer Science, Stanford University2016–2020
· Software Engineer, Google
· ESP Teacher, Stanford University
· Masters Student in Computer Science, Stanford University
· PhD Candidate, Developmental Biology, Stanford University
· Graduate Student in the Department of Developmental Biology, Stanford University School of Medicine

Publications (185)

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
Journal of the American Medical Association (JAMA) · 2014
1,597
cited
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.
Journal of Clinical Investigation · 2010
502
cited
Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience
Journal of Thoracic Oncology · 2015
365
cited
SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Clinical Cancer Research · 2012
295
cited
Rationale for co-targeting IGF-1R and ALK in ALK fusion positive lung cancer
Nature Medicine · 2014
265
cited
Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors.
Cancer Research · 2011
210
cited
Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Journal of Clinical Oncology · 2013
209
cited
DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett’s adenocarcinoma
Gut · 2008
181
cited
The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations—The Lung Cancer Mutation Consortium (LCMC2)
Clinical Cancer Research · 2017
167
cited
Targeting SLC1a5‐mediated glutamine dependence in non‐small cell lung cancer
International Journal of Cancer · 2015
156
cited
Longitudinal Cell‐Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse
Journal of Thoracic Oncology · 2018
123
cited
Proper inference from Simon's two‐stage designs
Statistics in Medicine · 2008
119
cited
Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules
American Journal of Respiratory and Critical Care Medicine · 2020
115
cited
EGFR Fusions as Novel Therapeutic Targets in Lung Cancer.
Cancer Discovery · 2016
112
cited
DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): A Catalog of Clinically Relevant Cancer Mutations to Enable Genome-Directed Anticancer Therapy
Clinical Cancer Research · 2013
111
cited
Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.
Biology of Blood and Marrow Transplantation · 2007
106
cited
Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma
Cancer · 2005
103
cited
Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib.
Journal of Clinical Oncology · 2007
92
cited
The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers
Proceedings of the National Academy of Sciences of the United States of America · 2015
92
cited
Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer
BMC Systems Biology · 2013
78
cited
Sotabase
Heidi Chen | Researcher Profile | Sotabase | Sotabase